期刊
AMERICAN JOURNAL OF PATHOLOGY
卷 192, 期 4, 页码 722-736出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2021.12.010
关键词
-
类别
资金
- National Institute of Health Research Cambridge Biomedical Research Centre at the Cambridge University Hospitals National Health Service Foundation Trust
The interaction between death receptor 3 (DR3) and E-selectin plays an important role in the progression of clear cell renal cell carcinoma (ccRCC).
Similar to the behavior of inflamed tubular epithelial cells, clear cell renal cell carcinoma (ccRCC) cells express death receptor 3 (DR3 or TNFSFR25) in situ, and expression increases with tumor grade. Surprisingly, E-selectin, which can be induced in endothelial cells by DR3 signaling, is also expressed by ccRCC cells and increases with tumor grade. In ccRCC organ cultures, addition of tumor necrosis factorelike 1A (TL1A or TNFSF15), the ligand for DR3, activates NF-kappa B and mitogen-activated protein kinases, induces both DR3 and E-selectin expression in an NF-kappa B-dependent manner, and promotes cell cycle entry. DR3 immunoprecipitated from ccRCC tissue contains sialyl Lewis X moieties (the ligand recognized by E-selectin), proximity ligation assays reveal DR3, and E-selectin interacts on ccRCC cells. Similar to that with the addition of TL1A, the addition of soluble E-selectin to ccRCC organ cultures activates NF-kappa B and mitogen-activated protein kinases in ccRCC cells and increases both DR3 and E-selectin expression and cell-cycle entry. In contrast, normal renal tubular epithelium, which poorly expresses DR3, is minimally responsive to either of these ligands. These data suggest a functional role for autocrine/paracrine DR3/E-selectin interactions in ccRCC and its progression, revealing a potential new target for therapeutic intervention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据